In further studies, we demonstrated that knockdown of CHAF1B was found to enhance the IFNα-induced antineoplastic effects against primary PV patient-derived progenitor cells in clonogenic assays (Fig. 4C). Here, CHAF1B is linked to acquired polycythemia vera.